期刊文献+

LAK细胞联合IL-2治疗小鼠胰腺癌的实验研究 被引量:2

Experimental Study on treating PantreaticCancer (MPO - 83 )with Lymphokineactivated Killer Cells Combined with in-terleukin - 2 in mouse Ou
下载PDF
导出
摘要 本试验在复制小鼠胰腺癌(MPC-83)皮下移植瘤基础上,进行了LAK细胞联合白细胞介素-2(IL-2)及单独IL-2抗小鼠胰腺癌作用观察。实验结果:LAK细胞与IL-2联用及IL-2单独应用均能明显地抑制移植MPC-83肿瘤在小鼠体内的生长,降低瘤发生率,提高荷瘤鼠的生存率。LAK细胞与IL-2联用抗肿瘤作用更显著,对肿瘤的抑制明显高于IL-2单独应用组。提示:LAK细胞加IL-2过继免疫疗法对小鼠胰腺(MPL-83)是敏感,有效的。 ntitumor effect against pancreatic cancer(MPC- 83) with Lan cells and IL - 2 wasobserved in mouse experiment. The LAK cellsadministration of combined with IL-2, or IL- 2 alone , could obviously depress the growthof the MPC-83 tumor, and improve the sur-vival rate in inouse during the experiment.The conibinant using of LAK cells and IL- 2was more effective. The restraint rate of thetumor produced by the combinant using LAKcells and IL-2 was markedly higher than thatIL - 2 alone, The experiment showed thatLan cells and IL- 2 are sensitive , effective tothe cancer (MPC-83) in mouse.
出处 《铁道医学》 1994年第4期204-205,共2页 Railway Medical Journal
关键词 有丝分裂因子 淋巴细胞癌 胰腺肿瘤 ancreatic cancer LAKcells interleukin- 2
  • 相关文献

参考文献1

二级参考文献3

  • 1陈慰峰,庞学文,张惠华,张孙曦,白俊海.Ⅰ—UdR释放试验测定杀伤T细胞的细胞毒作用[J]中国免疫学杂志,1985(04).
  • 2于永利,杨贵贞.人参花总皂甙在体外对小鼠NK活性的影响[J]中国免疫学杂志,1985(02).
  • 3Stephen E. Ettinghausen,Steven A. Rosenberg. The adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2[J] 1986,Springer Seminars in Immunopathology(1):51~71

共引文献1

同被引文献15

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部